In addition to production, the storage conditions of medicines, as well as the rules of the movement of goods and packaging during transportation will be changed.

The pharmaceutical market has set a six-month transition period for the introduction of the new standard.

After the introduction of GMP and GDP, the Ministry of Health and the country will join the EU standards in terms of quality control of pharmaceutical products.

"This process involves step-by-step review of applications and support to the sector to ensure, where possible, that they meet the standards set in terms of good distribution and business practice standards in a timely manner. As for the products imported - in this case, the deadline is set at 25 years, so that if the host country does not require the mandatory GMP/GDP standard, the import company will not be obliged to do so,"- the Deputy Minister of Health, Tamar Gabunia, said.